Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) | ![]() | +0.04 | |
| Volume | 651943 | ||
| 3:27 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027--
Enzon Pharmaceuticals Extends Tender Offer for a Portion of its Debt
Enzon Eliminates its Remaining 2008 Debt
Enzon Reports Significant Progress on the Reduction of Its Debt

Enzon Commences Phase II Trial of PEG-SN38
-- Conference Call With Principal Investigators to be Held Tomorrow--
Enzon Discontinues Further Development of rhMBL
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow
